Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 242.4 INR -3.73%
Market Cap: 5.5B INR
Have any thoughts about
Jenburkt Pharmaceuticals Ltd?
Write Note

Jenburkt Pharmaceuticals Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jenburkt Pharmaceuticals Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Jenburkt Pharmaceuticals Ltd
BSE:524731
Long-Term Investments
â‚ą319.6m
CAGR 3-Years
-9%
CAGR 5-Years
75%
CAGR 10-Years
59%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Investments
â‚ą7.1B
CAGR 3-Years
-5%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Investments
â‚ą12.2B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
13%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Investments
â‚ą68.1B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
23%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Investments
â‚ą650m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Investments
â‚ą3.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jenburkt Pharmaceuticals Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.

JENBURPH Intrinsic Value
785.72 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Jenburkt Pharmaceuticals Ltd's Long-Term Investments?
Long-Term Investments
319.6m INR

Based on the financial report for Sep 30, 2024, Jenburkt Pharmaceuticals Ltd's Long-Term Investments amounts to 319.6m INR.

What is Jenburkt Pharmaceuticals Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
59%

Over the last year, the Long-Term Investments growth was -6%. The average annual Long-Term Investments growth rates for Jenburkt Pharmaceuticals Ltd have been -9% over the past three years , 75% over the past five years , and 59% over the past ten years .

Back to Top